Iain R. Macpherson

University Avenue
Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications

Tissue-Free vs Tumor-Informed ctDNA Assays for Molecular Residual Disease Detection in Early Triple Negative Breast Cancer.

Tissue-Free vs Tumor-Informed ctDNA Assays for Molecular Residual Disease Detection in Early Triple Negative Breast Cancer.

Journal: JAMA oncology
Published: August 13, 2026

Understanding the patient journey: Barriers, facilitators, and expectations in joining a chemotherapy de-escalation trial among premenopausal patients with breast cancer.

Understanding the patient journey: Barriers, facilitators, and expectations in joining a chemotherapy de-escalation trial among premenopausal patients with breast cancer.

Journal: Breast (Edinburgh, Scotland)
Published: December 23, 2025

A trafficking regulatory subnetwork governs αVβ6 integrin-HER2 cross-talk to control breast cancer invasion and drug resistance.

A trafficking regulatory subnetwork governs αVβ6 integrin-HER2 cross-talk to control breast cancer invasion and drug resistance.

Journal: Science advances
Published: December 04, 2024

Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapes.

Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapes.

Journal: EMBO reports
Published: July 02, 2024

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.

Journal: Nature medicine
Published: June 05, 2024

Metabolic adaptations of micrometastases alter EV production to generate invasive microenvironments.

Metabolic adaptations of micrometastases alter EV production to generate invasive microenvironments.

Journal: The Journal of cell biology
Published: May 13, 2024

The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.

The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 04, 2024

Enhanced liver fibrosis (ELF) score predicts hepatic decompensation and mortality.

Enhanced liver fibrosis (ELF) score predicts hepatic decompensation and mortality.

Journal: JHEP reports : innovation in hepatology
Published: January 03, 2024

The impact of symptom clusters on endocrine therapy adherence in patients with breast cancer.

The impact of symptom clusters on endocrine therapy adherence in patients with breast cancer.

Journal: Breast (Edinburgh, Scotland)
Published: November 21, 2023

Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom.

Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom.

Journal: British journal of cancer
Published: October 27, 2023

Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT.

Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT.

Journal: Annals of hepatology
Published: October 04, 2023

Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial.

Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial.

Journal: Circulation
Published: September 25, 2023
Showing 1-12 of 70

Last Updated: 09/26/2026